BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

REGEN BIOLOGICS INC — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

REGEN BIOLOGICS INC

via HUTTON STRATEGIES

3rd Quarter (July 1 - Sep 30) · 2008Posted Oct 6, 2008Filing document ↗LDA record ↗

Income$40Kfee reported

Client

Name: REGEN BIOLOGICS INC
Description: Biologics company
Location: * Undetermined

Registrant

Firm: HUTTON STRATEGIES
Description: consulting & lobbying
Location: Bethesda, Maryland, United States of America

Lobbying activities

1 issue

Health Issues
Working with NJ Congressional delegation to resolve an issue with the FDA.
LobbyistsMICHAEL HUTTON
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.